Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive lipid-lowering regimens in acute coronary syndrome
ChiCTR1800018982Phase 4Not yet recruiting
- Sponsor
- Sir Run-Run Shaw Hospital
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of atorvastatin and ezetimibe in acute coronary syndrome (ACS) and coronary arteriosclerosis (2 arms), sponsored by Sir Run-Run Shaw Hospital. Primary endpoint: LDL-C variability. Planned start Jan 2019; status: not yet recruiting.
02
Drugs
atorvastatinezetimibe
03
Conditions
acute coronary syndrome (ACS)coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR1800018982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018982.